Latest & greatest articles for babies

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on babies or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on babies and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for babies

61. Pneumonia in the Immunocompetent Child.

healthy child, there is often a specific subgroup of bacteria, viruses, fungi, or mycobacterium most commonly implicated [6]. Among these, specific etiologies can vary based on age groups. Neonatal pneumonia is covered in a separate document that relates to fever in a neonate (see the ACR Appropriateness Criteria ® topic on “Fever Without Source or Unknown Origin—Child” [8]). For the infant, toddler, and preschool subgroups, viruses are the most common pathogens, with respiratory syncytial virus being (...) Pneumonia in the Immunocompetent Child. New 2019 ACR Appropriateness Criteria ® 1 Pneumonia in the Immunocompetent Child American College of Radiology ACR Appropriateness Criteria ® Pneumonia in the Immunocompetent Child Variant 1: Child. 3 months of age and older. Immunocompetent. Suspected uncomplicated community- acquired pneumonia in a well-appearing child who does not require hospitalization. Initial imaging. Procedure Appropriateness Category Relative Radiation Level Radiography chest

2019 American College of Radiology

62. Policy on the Use of Dental Bleaching for Child and Adolescent Patients

Policy on the Use of Dental Bleaching for Child and Adolescent Patients OFFICIAL BUT UNFORMATTED Policy on the Use of Dental Bleaching for Child and Adolescent Patients Review Council Council on Clinical Affairs Latest Revision 2019 Purpose The American Academy of Pediatric Dentistry (AAPD) recognizes that the desire for dental whitening in pediatric and adolescent patients has increased. This policy is intended to help professionals and patients make informed decisions about the indications (...) significantly during the mixed dentition. Full arch cosmetic bleaching during this developmental stage, however, would result in mismatched dental appearance once the child is in the permanent dentition. Adolescents present with unique dental needs, and the impact of tooth discoloration on an adolescent’s self-image could be considered an indication for bleaching. 8 Tooth whitening has been successful in adolescent patients using typical bleaching agents, 8 but research is lacking on the effects

2019 American Academy of Pediatric Dentistry

63. Head Trauma- Child

. The fracture threshold for an infant is approximately 10% that of a child or adult, and fractures have been reported in 11% of those <2 years old, compared with a prevalence of 2% in all children [3,32]. Axonal injury is also more common in these patients, likely due to the vulnerability of the immature white matter and the greater prevalence of nonaccidental trauma, which is often associated with shear injury and ischemia [1]. Such injuries are frequently occult by CT in infants as the low density (...) outcomes in children [61,63,66]. MRS may also provide insight into TBI, with ACR Appropriateness Criteria ® 10 Head Trauma — Child metabolite abnormalities such as increased lactate and decreased N-acetylaspartate correlating with severity of injury and prognosis in small studies, particularly in neonates and infants [62,67,68]. However, although advanced imaging offers future promise for more thorough assessment and understanding of TBI, these modalities remain generally understudied in pediatric head

2019 American College of Radiology

64. Interventions to improve disposal of child faeces for preventing diarrhoea and soil-transmitted helminth infection. Full Text available with Trip Pro

Interventions to improve disposal of child faeces for preventing diarrhoea and soil-transmitted helminth infection. Diarrhoea and soil-transmitted helminth (STH) infections represent a large disease burden worldwide, particularly in low-income countries. As the aetiological agents associated with diarrhoea and STHs are transmitted through faeces, the safe containment and management of human excreta has the potential to reduce exposure and disease. Child faeces may be an important source (...) of exposure even among households with improved sanitation.To assess the effectiveness of interventions to improve the disposal of child faeces for preventing diarrhoea and STH infections.We searched the Cochrane Infectious Diseases Group Specialized Register, CENTRAL, MEDLINE, Embase, and 10 other databases. We also searched relevant conference proceedings, contacted researchers, searched websites for organizations, and checked references from identified studies. The date of last search was 27 September

2019 Cochrane

65. Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants. (Abstract)

Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants. Germinal matrix-intraventricular haemorrhage (GMH-IVH) remains a substantial issue in neonatal intensive care units worldwide. Current therapies to prevent or treat GMH-IVH are limited. Stem cell-based therapies offer a potential therapeutic approach to repair, restore, and/or regenerate injured brain tissue. These preclinical findings have now culminated in ongoing (...) interventions other than MSCs of type or source versus stem cell-based interventions other than MSCs of other type or source; or (4) MSCs versus stem cell-based interventions other than MSCs. For prevention studies, we included extremely preterm infants (less than 28 weeks' gestation), 24 hours of age or less, without ultrasound diagnosis of GM-IVH; for treatment studies, we included preterm infants (less than 37 weeks' gestation), of any postnatal age, with ultrasound diagnosis of GM-IVH.For each

2019 Cochrane

66. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. (Abstract)

Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Infants born preterm (before 37 weeks' gestation) have poorer outcomes than infants at term, particularly if born before 32 weeks. Early cord clamping has been standard practice over many years, and enables quick transfer of the infant to neonatal care. Delayed clamping allows blood flow between the placenta, umbilical cord and baby to continue (...) , and may aid transition. Keeping baby at the mother's side enables neonatal care with the cord intact and this, along with delayed clamping, may improve outcomes. Umbilical cord milking (UCM) is proposed for increasing placental transfusion when immediate care for the preterm baby is needed. This Cochrane Review is a further update of a review first published in 2004 and updated in 2012.To assess the effects on infants born at less than 37 weeks' gestation, and their mothers of: 1) delayed cord

2019 Cochrane

67. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. (Abstract)

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Despite increasing worldwide use of anti-vascular endothelial growth factor agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular efficacy, the appropriate drug and dose, the need for retreatment, and the possibility of long-term systemic effects. We evaluated the efficacy and safety (...) of intravitreal ranibizumab compared with laser therapy in treatment of ROP.This randomised, open-label, superiority multicentre, three-arm, parallel group trial was done in 87 neonatal and ophthalmic centres in 26 countries. We screened infants with birthweight less than 1500 g who met criteria for treatment for retinopathy, and randomised patients equally (1:1:1) to receive a single bilateral intravitreal dose of ranibizumab 0·2 mg or ranibizumab 0·1 mg, or laser therapy. Individuals were stratified

2019 Lancet

68. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants (Abstract)

Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants To compare pulmonary and neurodevelopmental outcomes in extremely preterm infants with evolving bronchopulmonary dysplasia treated with either a 42-day course of dexamethasone or 9-day course(s) of dexamethasone.This was a prospective, randomized study in 59 infants ≤27 weeks of gestation born between October 2006 and December 2010, who (...) at day 10-21 of life had ventilatory support with mean airway pressure ≥8 cm H2O and FiO2 ≥60%. Infants received dexamethasone 0.5 mg/k/day × 3 days followed by a slow taper (42-day group, n = 30) or dexamethasone 0.5 mg/k/day followed by a rapid taper (9-day group, n = 29). Infants in the 9-day group received additional 9-day courses if they again required entry support. The primary outcome was intact survival (normal neurologic examination, IQ >70, and functioning in school without supplemental

2019 EvidenceUpdates

69. Newborn and infant physical examination: programme handbook

Newborn and infant physical examination: programme handbook Newborn and infant physical examination: programme handbook - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search The United Kingdom is leaving the European Union on 31 October 2019. Guidance Newborn and infant physical examination: programme handbook This document brings together all the guidelines that relate to the NHS newborn and infant physical (...) ) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details The purpose of this handbook is to inform and support best clinical practice in the NHS newborn and infant physical examination ( 27 August 2019 Updated NIPE programme handbook. 24 April 2018 Updated pathway appendices in accessible PDF formats. 19 April 2018 Minor correction to neonatal hip risk factors under Standard

2019 Public Health England

70. Child oral health: applying All Our Health

Child oral health: applying All Our Health Child oral health: applying All Our Health - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Child oral health: applying All Our Health Evidence and guidance to help healthcare professionals improve child oral health. Published 1 April 2015 Last updated 20 June 2019 — From: Documents HTML Details Examples and interventions that are recommended at population (...) , community and individual level to improve dental health for children. Published 1 April 2015 Last updated 20 June 2019 20 June 2019 Updated information on child oral health and added links to resources. 28 February 2018 Added Change4Life resources. 4 August 2017 Updated measuring outcomes section to add links to Everyday Interactions measuring impact toolkit and child oral health impact pathway. 1 April 2015 First published. Related content Collection Explore the topic Is this page useful? Thank you

2019 Public Health England

71. National child measurement programme: operational guidance

National child measurement programme: operational guidance National child measurement programme: operational guidance - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance National child measurement programme: operational guidance Guidance for local commissioners, providers and schools on running the national child measurement programme (NCMP). Published 2 May 2014 Last updated 17 July 2019 — From: Documents (...) use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Ref: PHE publications gateway number C4L301B https://campaignresources.phe.gov.uk/resources/campaigns/17/resources/63 Details The National child measurement programme ( . Published 2 May 2014 Last updated 17 July 2019 17 July 2019 Updated 'NCMP operational guidance

2019 Public Health England

72. Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. (Abstract)

Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection. Millions of children are hospitalised due to respiratory syncytial virus (RSV) infection every year. Treatment is supportive, and current therapies (e.g. inhaled bronchodilators, epinephrine, nebulised hypertonic saline, and corticosteroids) are ineffective or have limited effect. Respiratory syncytial virus immunoglobulin is sometimes used prophylactically to prevent hospital (...) admission from RSV-related illness. It may be considered for the treatment of established severe RSV infection or for treatment in an immunocompromised host, although it is not licenced for this purpose. It is unclear whether immunoglobulins improve outcomes when used as a treatment for established RSV infection in infants and young children admitted to hospital.  OBJECTIVES: To assess the effects of immunoglobulins for the treatment of RSV-proven lower respiratory tract infections in children aged up

2019 Cochrane

73. Association of China's universal two child policy with changes in births and birth related health factors: national, descriptive comparative study. Full Text available with Trip Pro

Association of China's universal two child policy with changes in births and birth related health factors: national, descriptive comparative study. To measure the association of China's universal two child policy, announced in October 2015, with changes in births and health related birth characteristics.National, descriptive before-and-after comparative study.Every county in 28 of 31 provinces of mainland China.Births included in two national databases: 67 786 749 births from county level (...) mean caesarean delivery rate among multiparous mothers increased by 1.2 percentage points (0.8 to 1.6) from 39.7% to 40.9%, and decreased by 3.0 percentage points (-3.5 to -2.5) among nulliparous mothers from 39.6% to 36.6%.Since its announcement in October 2015, the universal two child policy has been associated with a rise in births in China and with changes in health related birth characteristics: women giving birth have been more likely to be multiparous, and more likely to be aged 35 and over

2019 BMJ

74. Formula versus maternal breast milk for feeding preterm or low birth weight infants. (Abstract)

Formula versus maternal breast milk for feeding preterm or low birth weight infants. Artificial formula can be manipulated to contain higher amounts of macro-nutrients than maternal breast milk but breast milk confers important immuno-nutritional advantages for preterm or low birth weight (LBW) infants.To determine the effect of feeding preterm or LBW infants with formula compared with maternal breast milk on growth and developmental outcomes.We used the standard strategy of Cochrane Neonatal (...) to search the Cochrane Central Register of Controlled Trials (CENTRAL 2018, Issue 9), and Ovid MEDLINE, Ovid Embase, Ovid Maternity & Infant Care Database, and CINAHL to October 2018. We searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles.Randomised or quasi-randomised controlled trials that compared feeding preterm or low birth weight infants with formula versus maternal breast milk.Two review authors planned independently to assess trial

2019 Cochrane

75. Effect of antenatal dietary interventions in maternal obesity on pregnancy weight-gain and birthweight: Healthy Mums and Babies (HUMBA) randomized trial (Abstract)

Effect of antenatal dietary interventions in maternal obesity on pregnancy weight-gain and birthweight: Healthy Mums and Babies (HUMBA) randomized trial Pregnancy interventions that improve maternal and infant outcomes are urgently needed in populations with high rates of obesity. We undertook the Healthy Mums and Babies (HUMBA) randomized controlled trial to assess the effect of dietary interventions and or probiotics in a multiethnic population of pregnant women with obesity, living (...) to a dietary intervention (4 tailored educational sessions at ≤28 weeks' gestation by a community health worker trained in key aspects of pregnancy nutrition plus text messaging until birth) or to routine dietary advice; and to daily capsules containing either (Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12, minimum 6.5 × 109 colony forming units), or placebo, until birth. Analysis was by intention to treat with adjustment for maternal baseline body mass index. Infant outcomes were additionally

2019 EvidenceUpdates

76. Improving incidence trends of severe intraventricular haemorrhages in preterm infants at 32 weeks gestation: a cohort study (Abstract)

Improving incidence trends of severe intraventricular haemorrhages in preterm infants at 32 weeks gestation: a cohort study To describe the trend and risk factors for severe intraventricular haemorrhage (IVH) among infants <32 weeks gestation.Population-based cohort study.Australia and New Zealand.All preterm infants <32 weeks gestation in the Australian and New Zealand Neonatal Network (ANZNN) from 1995 to 2012.Comparison of IVH incidence between 6-year epochs.Overall IVH and severe IVH (...) incidence.A total of 60 068 infants were included, and overall survival to discharge increased from 89% to 93% over the three epochs. As the percentage of infants with IVH decreased from 23.6% to 21.3% and 21.4% (p<0.001) from epoch 1 to 3, respectively, fewer survivors had severe IVH (4.0%, 3.3% and 2.8%, respectively, p<0.001). Over time, there were fewer antenatal complications, higher antenatal steroid usage and more caesarean-section births. Fewer infants were intubated at birth, had low 5 min Apgar

2019 EvidenceUpdates

77. Protein hydrolysate versus standard formula for preterm infants. Full Text available with Trip Pro

Protein hydrolysate versus standard formula for preterm infants. When human milk is not available for feeding preterm infants, protein hydrolysate, rather than standard cow's milk formulas (with intact proteins), is often used because it is perceived as being tolerated better and less likely to lead to complications. However, protein hydrolysate formulas are more expensive than standard formulas, and concern exists that their use in practice is not supported by high-quality evidence.To assess (...) the effects of feeding preterm infants hydrolysed formula (vs standard cow's milk formula) on risk of feed intolerance, necrotising enterocolitis, and other morbidity and mortality.We used the standard Cochrane Neonatal search strategy including electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 1), in the Cochrane Library; Ovid MEDLINE (1966 to 28 January 2019); Ovid Embase (1980 to 28 January 2019); and the Cumulative Index to Nursing and Allied Health

2019 Cochrane

78. Formula versus donor breast milk for feeding preterm or low birth weight infants. Full Text available with Trip Pro

Formula versus donor breast milk for feeding preterm or low birth weight infants. When sufficient maternal breast milk is not available, alternative forms of enteral nutrition for preterm or low birth weight (LBW) infants are donor breast milk or artificial formula. Donor breast milk may retain some of the non-nutritive benefits of maternal breast milk for preterm or LBW infants. However, feeding with artificial formula may ensure more consistent delivery of greater amounts of nutrients (...) differences (MDs) for continuous data, with respective 95% confidence intervals (CIs). We used a fixed-effect model in meta-analyses and explored potential causes of heterogeneity in subgroup analyses. We assessed the certainty of evidence for the main comparison at the outcome level using GRADE methods.Twelve trials with a total of 1879 infants fulfilled the inclusion criteria. Four trials compared standard term formula versus donor breast milk and eight compared nutrient-enriched preterm formula versus

2019 Cochrane

79. Nutrient-enriched formula versus standard formula for preterm infants. (Abstract)

Nutrient-enriched formula versus standard formula for preterm infants. Preterm infants may accumulate nutrient deficits leading to extrauterine growth restriction. Feeding preterm infants with nutrient-enriched rather than standard formula might increase nutrient accretion and growth rates and might improve neurodevelopmental outcomes.To compare the effects of feeding with nutrient-enriched formula versus standard formula on growth and development of preterm infants.We used the Cochrane (...) Neonatal standard search strategy. This included electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 11), MEDLINE, Embase, and the Cumulative Index to Nursing and Allied Health Literature (until November 2018), as well as conference proceedings, previous reviews, and clinical trials databases.Randomised and quasi-randomised controlled trials that compared feeding preterm infants with nutrient-enriched formula (protein and energy plus minerals, vitamins

2019 Cochrane

80. Exposure to the smell and taste of milk to accelerate feeding in preterm infants. (Abstract)

Exposure to the smell and taste of milk to accelerate feeding in preterm infants. Preterm infants are often unable to co-ordinate sucking, swallowing and breathing for oral feeding because of their immaturity; in such cases, initial nutrition is provided by orogastric or nasogastric tube feeding. Feed intolerance is common and can delay attainment of full enteral feeds and sucking feeds, which prolongs the need for intravenous nutrition and hospital stay. Smell and taste play an important role (...) in the activation of physiological pre-absorptive processes that contribute to food digestion and absorption. However, during tube feedings, milk bypasses the nasal and oral cavities, which limits exposure to the smell and taste of milk. Provision of the smell and taste of milk with tube feedings is non-invasive and inexpensive; and if it does accelerate the transition to enteral feeds, and then to sucking feeds, it would be of considerable potential benefit to infants, their families, and the healthcare

2019 Cochrane